Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
Offer reference number: CM/PHR/22/5678
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbvie Ltd | 08004972 | ~£688,010,000 estimated from lot values | LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Accord-UK Ltd | 00079585 | ~£688,010,000 estimated from lot values | - |
| Almirall | 06320852 | ~£688,010,000 estimated from lot values | - |
| Amgen Ltd | 02354269 | ~£688,010,000 estimated from lot values | - |
| AstraZeneca | 03674842 | ~£688,010,000 estimated from lot values | LOBBYIST FTI Consulting LLP (6 quarters) Incisive Health Ltd (6 quarters) Teneo Strategy Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Aventis Pharma ltd t/a Sanofi | 01535640 | ~£688,010,000 estimated from lot values | DONOR£101K across 3 donations To: Pauline Latham MP, Derek Thomas, Labour Party |
| Bayer Plc | 16954143 | ~£688,010,000 estimated from lot values | - |
| Biogen | 06151086 | ~£688,010,000 estimated from lot values | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£688,010,000 estimated from lot values | - |
| Chugai Pharma UK Ltd | 02814621 | ~£688,010,000 estimated from lot values | - |
| CST Pharma Limited | 04212740 | ~£688,010,000 estimated from lot values | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£688,010,000 estimated from lot values | - |
| Eli Lilly & Company Ltd | 00284385 | ~£688,010,000 estimated from lot values | DONOR£9K across 1 donation To: Conservative and Unionist Party |
| Galapagos Biotech Ltd | 03400161 | ~£688,010,000 estimated from lot values | - |
| Gedeon Richter UK Ltd | 04325685 | ~£688,010,000 estimated from lot values | - |
| GlaxoSmithKline UK Limited | 04310159 | ~£688,010,000 estimated from lot values | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
| Ipsen | 06751069 | ~£688,010,000 estimated from lot values | LOBBYIST Burkitt Communications Ltd (2 quarters) WA Communications Ltd (1 quarter) |
| Janssen-Cilag Ltd | 01027904 | ~£688,010,000 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Kent Pharma Ltd | - | ~£688,010,000 estimated from lot values | - |
| Merck Serono Limited | 00990823 | ~£688,010,000 estimated from lot values | MP LINK Munira Wilson— Employment and earnings |
| Merck Sharpe & Dohme (UK) Limited | - | ~£688,010,000 estimated from lot values | - |
| Merz | - | ~£688,010,000 estimated from lot values | - |
| Mylan | 05460854 | ~£688,010,000 estimated from lot values | - |
| Napp Pharmaceuticals Ltd | 03690299 | ~£688,010,000 estimated from lot values | - |
| Neon Healthcare Ltd | 06844351 | ~£688,010,000 estimated from lot values | - |
| Novartis Pharmaceuticals UK Ltd | 00119006 | ~£688,010,000 estimated from lot values | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
| Novo Nordisk | 01118740 | ~£688,010,000 estimated from lot values | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Organon Pharmaceuticals UK Ltd | - | ~£688,010,000 estimated from lot values | - |
| Orifarm UK | 10015046 | ~£688,010,000 estimated from lot values | - |
| Pfizer Ltd | 00526209 | ~£688,010,000 estimated from lot values | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Hanover Communications International Limited (3 quarters) Ovid Consulting Ltd (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Pharmacosmos UK Ltd | 03104505 | ~£688,010,000 estimated from lot values | - |
| Roche Products Ltd | 00100674 | ~£688,010,000 estimated from lot values | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Sandoz Ltd | 01547204 | ~£688,010,000 estimated from lot values | - |
| Sobi (Swedish Orphan Biovitrum Ltd) | - | ~£688,010,000 estimated from lot values | - |
| Sun Pharma UK Ltd | 02992795 | ~£688,010,000 estimated from lot values | - |
| Teva UK Limited | 00302461 | ~£688,010,000 estimated from lot values | - |
| Thornton and Ross Ltd | 00185947 | ~£688,010,000 estimated from lot values | - |
| Vifor Pharma UK Ltd | 06514784 | ~£688,010,000 estimated from lot values | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£688,010,000 estimated from lot values | - |
Government spending data: These suppliers have received £1,190,926,042 in 6,500 payments (over £25k) from UK Health Security Agency, Manchester University NHS Foundation Trust, Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT and 22 more public bodies (2010-04-28 to 2026-03-31).